Enlaza Therapeutics
Enlaza Therapeutics is a startup headquartered in La Jolla, United States, founded in 2020. It has raised at least $99.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Enlaza Therapeutics has raised at least $99.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Enlaza Therapeutics sits inside the San Diego R&D ecosystem in the Global R&D Labs Directory.
Other startups in La Jolla
- A28 Therapeutics
- AeroRx Therapeutics
- Arialys Therapeutics
- DEPTH Health
- Paulex Bio
- RightDevice
- Sylke
- Valora Therapeutics
Related
- Innovation profile of La Jolla
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Enlaza Therapeutics do?
Enlaza Therapeutics is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Enlaza Therapeutics raised?
At least $99.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Enlaza Therapeutics based?
Enlaza Therapeutics is headquartered in La Jolla, United States.
When was Enlaza Therapeutics founded?
Enlaza Therapeutics was founded in 2020.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.